Paying users zone. Data is covered by .

  • Get to Abbott Laboratories for $17.99, or

  • get to whole website for at least 3 months from $49.99.

 

$17.99


Ratios (Summary)

Abbott Laboratories, short-term (operating) activity ratios

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Turnover Ratios
Inventory turnover
Receivables turnover
Payables turnover
Working capital turnover
Average No. of Days
Average inventory processing period
Add: Average receivable collection period
Operating cycle
Less: Average payables payment period
Cash conversion cycle

Source: Based on data from Abbott Laboratories Annual Reports

Ratio Description The company
Inventory turnover An activity ratio calculated as cost of goods sold divided by inventory. Abbott Laboratories's inventory turnover improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level.
Receivables turnover An activity ratio equal to revenue divided by receivables. Abbott Laboratories's receivables turnover improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
Payables turnover An activity ratio calculated as cost of goods sold divided by payables. Abbott Laboratories's payables turnover declined from 2015 to 2016 and from 2016 to 2017.
Working capital turnover An activity ratio calculated as revenue divided by working capital. Abbott Laboratories's working capital turnover deteriorated from 2015 to 2016 but then slightly improved from 2016 to 2017.
Average inventory processing period An activity ratio equal to the number of days in the period divided by inventory turnover over the period. Abbott Laboratories's average inventory processing period improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level.
Average receivable collection period An activity ratio equal to the number of days in the period divided by receivables turnover. Abbott Laboratories's average receivable collection period improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
Operating cycle Equal to average inventory processing period plus average receivables collection period. Abbott Laboratories's operating cycle improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
Average payables payment period An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. Abbott Laboratories's average payables payment period increased from 2015 to 2016 and from 2016 to 2017.
Cash conversion cycle A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. Abbott Laboratories's cash conversion cycle improved from 2015 to 2016 and from 2016 to 2017.

Top


Inventory Turnover

Abbott Laboratories, inventory turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Cost of products sold, excluding amortization of intangible assets
Inventories
Ratio
Inventory turnover1
Benchmarks
Inventory Turnover, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Inventory Turnover, Sector
Pharmaceuticals & Biotechnology
Inventory Turnover, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Inventory turnover = Cost of products sold, excluding amortization of intangible assets ÷ Inventories
= ÷ =

Ratio Description The company
Inventory turnover An activity ratio calculated as cost of goods sold divided by inventory. Abbott Laboratories's inventory turnover improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level.

Top


Receivables Turnover

Abbott Laboratories, receivables turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net sales
Trade receivables, less allowances
Ratio
Receivables turnover1
Benchmarks
Receivables Turnover, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Receivables Turnover, Sector
Pharmaceuticals & Biotechnology
Receivables Turnover, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Receivables turnover = Net sales ÷ Trade receivables, less allowances
= ÷ =

Ratio Description The company
Receivables turnover An activity ratio equal to revenue divided by receivables. Abbott Laboratories's receivables turnover improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Payables Turnover

Abbott Laboratories, payables turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Cost of products sold, excluding amortization of intangible assets
Trade accounts payable
Ratio
Payables turnover1
Benchmarks
Payables Turnover, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Payables Turnover, Sector
Pharmaceuticals & Biotechnology
Payables Turnover, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Payables turnover = Cost of products sold, excluding amortization of intangible assets ÷ Trade accounts payable
= ÷ =

Ratio Description The company
Payables turnover An activity ratio calculated as cost of goods sold divided by payables. Abbott Laboratories's payables turnover declined from 2015 to 2016 and from 2016 to 2017.

Top


Working Capital Turnover

Abbott Laboratories, working capital turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Current assets
Less: Current liabilities
Working capital
Net sales
Ratio
Working capital turnover1
Benchmarks
Working Capital Turnover, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Working Capital Turnover, Sector
Pharmaceuticals & Biotechnology
Working Capital Turnover, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Working capital turnover = Net sales ÷ Working capital
= ÷ =

Ratio Description The company
Working capital turnover An activity ratio calculated as revenue divided by working capital. Abbott Laboratories's working capital turnover deteriorated from 2015 to 2016 but then slightly improved from 2016 to 2017.

Top


Average Inventory Processing Period

Abbott Laboratories, average inventory processing period calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Inventory turnover
Ratio (no. of days)
Average inventory processing period1
Benchmarks (no. of days)
Average Inventory Processing Period, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Average Inventory Processing Period, Sector
Pharmaceuticals & Biotechnology
Average Inventory Processing Period, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ =

Ratio Description The company
Average inventory processing period An activity ratio equal to the number of days in the period divided by inventory turnover over the period. Abbott Laboratories's average inventory processing period improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level.

Top


Average Receivable Collection Period

Abbott Laboratories, average receivable collection period calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Receivables turnover
Ratio (no. of days)
Average receivable collection period1
Benchmarks (no. of days)
Average Receivable Collection Period, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Average Receivable Collection Period, Sector
Pharmaceuticals & Biotechnology
Average Receivable Collection Period, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ =

Ratio Description The company
Average receivable collection period An activity ratio equal to the number of days in the period divided by receivables turnover. Abbott Laboratories's average receivable collection period improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Operating Cycle

Abbott Laboratories, operating cycle calculation, comparison to benchmarks

No. of days

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Average inventory processing period
Average receivable collection period
Ratio
Operating cycle1
Benchmarks
Operating Cycle, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Operating Cycle, Sector
Pharmaceuticals & Biotechnology
Operating Cycle, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Operating cycle = Average inventory processing period + Average receivable collection period
= + =

Ratio Description The company
Operating cycle Equal to average inventory processing period plus average receivables collection period. Abbott Laboratories's operating cycle improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Average Payables Payment Period

Abbott Laboratories, average payables payment period calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Payables turnover
Ratio (no. of days)
Average payables payment period1
Benchmarks (no. of days)
Average Payables Payment Period, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Average Payables Payment Period, Sector
Pharmaceuticals & Biotechnology
Average Payables Payment Period, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ =

Ratio Description The company
Average payables payment period An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. Abbott Laboratories's average payables payment period increased from 2015 to 2016 and from 2016 to 2017.

Top


Cash Conversion Cycle

Abbott Laboratories, cash conversion cycle calculation, comparison to benchmarks

No. of days

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Average inventory processing period
Average receivable collection period
Average payables payment period
Ratio
Cash conversion cycle1
Benchmarks
Cash Conversion Cycle, Competitors
AbbVie Inc.
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Cash Conversion Cycle, Sector
Pharmaceuticals & Biotechnology
Cash Conversion Cycle, Industry
Health Care

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= + =

Ratio Description The company
Cash conversion cycle A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. Abbott Laboratories's cash conversion cycle improved from 2015 to 2016 and from 2016 to 2017.

Top